FREDRICK ODONGO: Open Payments
NPI 1104582006 · ARLINGTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$38,162 in 71 payments from 5 companies in 2025. Trend: 2023 $184 · 2024 $510 · 2025 $38,162
Speaker / faculty: $27,192Consulting: $6,188Travel & lodging: $3,468Food & beverage: $1,315
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 64 | $37,765 |
| Janssen Pharmaceuticals, Inc | 3 | $232 |
| Teva Pharmaceuticals USA, Inc. | 1 | $116 |
| Alpha Cognition USA, Inc. | 2 | $26 |
| ACADIA Pharmaceuticals Inc | 1 | $23 |
Products named: INGREZZA, INVEGA SUSTENNA, AUSTEDO XR, Zunveyl, NUPLAZID.
Industry payments across TX — which companies pay providers there.
